Washington, Aug 22 (IANS) The US has fined top drug-making companies Teva Pharmaceuticals and Glenmark Pharmaceuticals (NS: GLEN ) a total of $255 million for price-fixing fixing medications, including a generic cholesterol drug that they will now divest. The Department of Justice (DoJ) announced that Teva will also make a…Read More
US fines Teva Glenmark 255 mn over drug pricefixing charges
